Baxter International Inc. · BAX · Next earnings

Baxter International Inc. reports Thursday, Oct 29, 2026

BAX reports before market open with consensus EPS at $0.52 and revenue at $2.91B. Last quarter: Baxter Q1 2026: EPS Beats on Turnaround Momentum, Novum Headwinds Persist

Reports Before market open39 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $0.52 Calendar consensus
Consensus revenue $2.91B Calendar consensus
Report date Oct 29, 2026 Thursday, date estimated
Session Before market open 39 days away

Where BAX left off: FY2026 Q1

Full report

Baxter Q1 2026: EPS Beats on Turnaround Momentum, Novum Headwinds Persist

EPS surprise +15.8% Reported $0.36 vs $0.31
Revenue surprise +3.3% Reported $2.70B vs $2.62B
Stock move +4.0% Event window
Subsequent drift +6.8% Up to 20 sessions

Guidance was maintained with no change from the prior outlook. Management reiterated full-year 2026 targets of flat to 1% reported sales growth and operating margin expansion to 13 to 14 percent. The company also reaffirmed its target of approximately 3x net leverage by end-2026 through debt pay-down.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Tariff and inflationary pressures on manufacturing costs.
  • Novum LVP shipment and installation hold, with potential customer returns and ongoing regulatory remediation.
  • Supply constraints at a contract manufacturer affecting injectable pharmaceuticals.
  • Macroeconomic uncertainty, including oil price volatility and geopolitical conflict.
  • Higher interest expense impacting non-operating costs.

Questions analysts left open

  • Assumptions underlying flat organic growth guidance.
  • Potential financial impact of Novum pump returns on revenue and margins.
  • Extent of inflationary cost pressures and oil price exposure.
  • Supply chain risks, especially chip and component availability.
  • HST order trends and timing of Front Line Care installations.

Ask FN2 about BAX next report

Transcript, numbers and history already loaded
What should I watch for in BAX's next earnings report?How did BAX guide last quarter, and is consensus above or below that?Give me the bull and bear case going into BAX earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the BAX recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent BAX quarters

All BAX earnings
+4.0%FY2026 Q1

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q1

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.